A CD38/CD3xCD28 trispecific T-cell engager as a potentially active agent in multiple myeloma patients relapsed and/or refractory to anti-CD38 monoclonal antibodies

  1. Zabaleta, A.
  2. Blanco, L.
  3. Kim, P.S.
  4. Bisht, K.
  5. Wang, H.
  6. Van de Velde, H.
  7. Lasa, M.
  8. Tamariz-Amador, L.-E.
  9. Rodriguez-Otero, P.
  10. San-Miguel, J.
  11. Paiva, B.
  12. Martín-Sánchez, E.
Revue:
British Journal of Haematology

ISSN: 1365-2141 0007-1048

Année de publication: 2024

Type: Article

DOI: 10.1111/BJH.19784 GOOGLE SCHOLAR